GIUSEPPE DI BELLA > NEWS > null > null > La Vitamina C nelle malattie linfoproliferative

 
La Vitamina C nelle malattie linfoproliferative di S.I.B.O.R. - M.D.B.
 
 
Data: 14/07/2006
Tipologia: MDB - Documentazione
Lingua: Italiano
Anno: 2006
 
 
Descrizione:
PER LEGGERE E SCARICARE IL CAPITOLO SULLA VITAMINA C, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 36 pagine in formato PDF e pesa 116 kb.



BIBLIOGRAFIA





Aidoo, A., L. E. Lyn-Cook, et al. (1994). "Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo." Environ Mol Mutagen 24(3): 220-8.





Ashino, H., M. Shimamura, et al. (2003). "Novel function of ascorbic acid as an angiostatic factor." Angiogenesis 6(4): 259-69.





Bendich, A. and L. Langseth (1995). "The health effects of vitamin C supplementation: a review." J Am Coll Nutr 14(2): 124-36.





Cameron, E. (1991). "Protocol for the use of vitamin C in the treatment of cancer." Med Hypotheses 36(3): 190-4.





Cameron, E. and A. Campbell (1974). "The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer." Chem Biol Interact 9(4): 285-315.





Cameron, E. and L. Pauling (1973). "Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases." Oncology 27(2): 181-92.





Cameron, E. and L. Pauling (1976). "Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer." Proc Natl Acad Sci U S A 73(10): 3685-9.





Cameron, E. and L. Pauling (1978). "Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer." Proc Natl Acad Sci U S A 75(9): 4538-42.





Cameron, E., L. Pauling, et al. (1979). "Ascorbic acid and cancer: a review." Cancer Res 39(3): 663-81.





Creagan, E. T., C. G. Moertel, et al. (1979). "Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial." N Engl J Med 301(13): 687-90.





Fujita, K., K. Shinpo, et al. (1982). "Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs." Cancer Res 42(1): 309-16.





Head, K. A. (1998). "Ascorbic acid in the prevention and treatment of cancer." Altern Med Rev 3(3): 174-86.





Helgestad, J., R. Pettersen, et al. (1990). "Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid." Eur J Haematol 44(1): 9-17.





Kao, T. L., W. J. Meyer, 3rd, et al. (1993). "Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines." Cancer Lett 70(1-2): 101-6.





Kurbacher, C. M., U. Wagner, et al. (1996). "Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro." Cancer Lett 103(2): 183-9.





Lee, K. W., H. J. Lee, et al. (2002). "Preventive effects of vitamin C on carcinogenesis." Lancet 359(9301): 172.





Lee, Y. S. and R. D. Wurster (1994). "Potentiation of anti-proliferative effect of nitroprusside by ascorbate in human brain tumor cells." Cancer Lett 78(1-3): 19-23.





Levine, M., C. Conry-Cantilena, et al. (1996). "Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance." Proc Natl Acad Sci U S A 93(8): 3704-9.





Michel, L., A. Dupuy, et al. (2003). "Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)." J Invest Dermatol 121(4): 881-93.





Moertel, C. G., T. R. Fleming, et al. (1985). "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison." N Engl J Med 312(3): 137-41.





Murata, A., F. Morishige, et al. (1982). "Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate." Int J Vitam Nutr Res Suppl 23: 103-13.





Nagy, B., I. Mucsi, et al. (2003). "Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro." In Vivo 17(3): 289-92.





Ozturk, G., C. W. Mulholland, et al. (2001). "Vitamin C decreases intracellular calcium level in human lymphoid cells." J Physiol Pharmacol 52(2): 285-92.





Padh, H. (1991). "Vitamin C: newer insights into its biochemical functions." Nutr Rev 49(3): 65-70.





Peterkofsky, B. (1991). "Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy." Am J Clin Nutr 54(6 Suppl): 1135S-1140S.





Pinnel, S. R., S. Murad, et al. (1987). "Induction of collagen synthesis by ascorbic acid. A possible mechanism." Arch Dermatol 123(12): 1684-6.





Prasad, K. N., C. Hernandez, et al. (1994). "Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins." Nutr Cancer 22(3): 233-45.





Prasad, S. B., A. Giri, et al. (1992). "Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma." Pol J Pharmacol Pharm 44(4): 383-91.





Sarna, S. and R. K. Bhola (1993). "Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro." Arch Immunol Ther Exp (Warsz) 41(5-6): 327-33.





Sauberlich, H. E. (1994). "Pharmacology of vitamin C." Annu Rev Nutr 14: 371-91.





Shimpo, K., T. Nagatsu, et al. (1991). "Ascorbic acid and adriamycin toxicity." Am J Clin Nutr 54(6 Suppl): 1298S-1301S.





Utoguchi, N., K. Ikeda, et al. (1995). "Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer." J Cell Physiol 163(2): 393-9.





Ward, M. H., S. H. Zahm, et al. (1994). "Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)." Cancer Causes Control 5(5): 422-32.

 
 
 

PER LEGGERE E SCARICARE IL CAPITOLO SULLA VITAMINA C, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 36 pagine in formato PDF e pesa 116 kb.



BIBLIOGRAFIA





Aidoo, A., L. E. Lyn-Cook, et al. (1994). "Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo." Environ Mol Mutagen 24(3): 220-8.





Ashino, H., M. Shimamura, et al. (2003). "Novel function of ascorbic acid as an angiostatic factor." Angiogenesis 6(4): 259-69.





Bendich, A. and L. Langseth (1995). "The health effects of vitamin C supplementation: a review." J Am Coll Nutr 14(2): 124-36.





Cameron, E. (1991). "Protocol for the use of vitamin C in the treatment of cancer." Med Hypotheses 36(3): 190-4.





Cameron, E. and A. Campbell (1974). "The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer." Chem Biol Interact 9(4): 285-315.





Cameron, E. and L. Pauling (1973). "Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases." Oncology 27(2): 181-92.





Cameron, E. and L. Pauling (1976). "Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer." Proc Natl Acad Sci U S A 73(10): 3685-9.





Cameron, E. and L. Pauling (1978). "Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer." Proc Natl Acad Sci U S A 75(9): 4538-42.





Cameron, E., L. Pauling, et al. (1979). "Ascorbic acid and cancer: a review." Cancer Res 39(3): 663-81.





Creagan, E. T., C. G. Moertel, et al. (1979). "Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial." N Engl J Med 301(13): 687-90.





Fujita, K., K. Shinpo, et al. (1982). "Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs." Cancer Res 42(1): 309-16.





Head, K. A. (1998). "Ascorbic acid in the prevention and treatment of cancer." Altern Med Rev 3(3): 174-86.





Helgestad, J., R. Pettersen, et al. (1990). "Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid." Eur J Haematol 44(1): 9-17.





Kao, T. L., W. J. Meyer, 3rd, et al. (1993). "Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines." Cancer Lett 70(1-2): 101-6.





Kurbacher, C. M., U. Wagner, et al. (1996). "Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro." Cancer Lett 103(2): 183-9.





Lee, K. W., H. J. Lee, et al. (2002). "Preventive effects of vitamin C on carcinogenesis." Lancet 359(9301): 172.





Lee, Y. S. and R. D. Wurster (1994). "Potentiation of anti-proliferative effect of nitroprusside by ascorbate in human brain tumor cells." Cancer Lett 78(1-3): 19-23.





Levine, M., C. Conry-Cantilena, et al. (1996). "Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance." Proc Natl Acad Sci U S A 93(8): 3704-9.





Michel, L., A. Dupuy, et al. (2003). "Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)." J Invest Dermatol 121(4): 881-93.





Moertel, C. G., T. R. Fleming, et al. (1985). "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison." N Engl J Med 312(3): 137-41.





Murata, A., F. Morishige, et al. (1982). "Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate." Int J Vitam Nutr Res Suppl 23: 103-13.





Nagy, B., I. Mucsi, et al. (2003). "Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro." In Vivo 17(3): 289-92.





Ozturk, G., C. W. Mulholland, et al. (2001). "Vitamin C decreases intracellular calcium level in human lymphoid cells." J Physiol Pharmacol 52(2): 285-92.





Padh, H. (1991). "Vitamin C: newer insights into its biochemical functions." Nutr Rev 49(3): 65-70.





Peterkofsky, B. (1991). "Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy." Am J Clin Nutr 54(6 Suppl): 1135S-1140S.





Pinnel, S. R., S. Murad, et al. (1987). "Induction of collagen synthesis by ascorbic acid. A possible mechanism." Arch Dermatol 123(12): 1684-6.





Prasad, K. N., C. Hernandez, et al. (1994). "Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins." Nutr Cancer 22(3): 233-45.





Prasad, S. B., A. Giri, et al. (1992). "Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma." Pol J Pharmacol Pharm 44(4): 383-91.





Sarna, S. and R. K. Bhola (1993). "Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro." Arch Immunol Ther Exp (Warsz) 41(5-6): 327-33.





Sauberlich, H. E. (1994). "Pharmacology of vitamin C." Annu Rev Nutr 14: 371-91.





Shimpo, K., T. Nagatsu, et al. (1991). "Ascorbic acid and adriamycin toxicity." Am J Clin Nutr 54(6 Suppl): 1298S-1301S.





Utoguchi, N., K. Ikeda, et al. (1995). "Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer." J Cell Physiol 163(2): 393-9.





Ward, M. H., S. H. Zahm, et al. (1994). "Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)." Cancer Causes Control 5(5): 422-32.

 
 
 

 

Documento Allegato

Stampa